UK markets open in 7 hours 25 minutes
NIKKEI 225
38,073.98 -128.42 (-0.34%) HANG SENG
18,537.81 +223.91 (+1.22%) CRUDE OIL
79.65 +0.39 (+0.49%) GOLD FUTURES
2,355.00 +14.70 (+0.63%) DOW
39,387.76 +331.36 (+0.85%) Bitcoin GBP
50,276.57 +1,556.16 (+3.19%)
Sangamo Therapeutics Inc (GBY.MU)
Munich - Munich Delayed price. Currency in EUR
Add to watchlist
At close: 08:03AM CEST
| Previous close | 0.5006 |
| Open | 0.4780 |
| Bid | 0.4093 x N/A |
| Ask | 0.5620 x N/A |
| Day's range | 0.4780 - 0.4780 |
| 52-week range | 0.2819 - 1.4498 |
| Volume | |
| Avg. volume | 215 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates
Sangamo (SGMO) delivered earnings and revenue surprises of -22.73% and 94.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
Cardiff Oncology (CRDF) delivered earnings and revenue surprises of 12% and 86.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
What You Need To Know About The Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analyst Downgrade Today
One thing we could say about the analysts on Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ) - they aren't optimistic...
© 2024 Yahoo. All rights reserved.